Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

1
Player Avatar cougarVF61 (36.58) Submitted: 11/11/2011 9:00:19 PM : Outperform Start Price: $30.90 BMY Score: +2.33

product line & mgm't innovations

Report this Post Reply

Featured Broker Partners


Advertisement